Research graph
References from Serum Protein Panel Facilitates Surgical Decision-Making for Barcelona Stage B Hepatocellular Carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2021 · External reference
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
10.1016/j.jhep.2021.11.018 · 2022 · External reference
Association between physical activity and risk of hepatobiliary cancers: a multinational cohort study
10.1016/j.jhep.2018.12.014 · 2019 · External reference
A global investment framework for the elimination of hepatitis B
10.1016/j.jhep.2020.09.013 · 2021 · External reference
Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective
10.3350/cmh.2022.0399 · 2023 · External reference
Liver resection for single large hepatocellular carcinoma: a prognostic factors study
10.1016/j.aohep.2022.100739 · 2022 · External reference
Outcomes of liver resection for huge hepatocellular carcinoma exceeding 10 cm in size: a single center experience
10.1016/j.amjsurg.2022.12.005 · 2023 · External reference
Treatment of intermediate-stage hepatocellular carcinoma
10.1038/nrclinonc.2014.122 · 2014 · External reference
A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? an observational study of the HCC East-West study group
10.1097/sla.0b013e31828329b8 · 2013 · External reference
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: a RCT
10.1016/j.jhep.2014.08.057 · 2015 · External reference
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions
2012 · External reference
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
10.1016/s1470-2045(08)70284-5 · 2009 · External reference
Subclassification of BCLC B stage hepatocellular carcinoma and treatment strategies: proposal of modified Bolondi's subclassification (Kinki criteria)
10.1159/000439290 · 2015 · External reference
Proteomic profiling and artificial intelligence for hepatocellular carcinoma translational medicine
10.3390/biomedicines9020159 · 2021 · External reference
A preoperative model to predict overall survival in patients with hepatoma undergoing resection
10.1016/j.amjsurg.2024.115778 · 2024 · External reference
Computational data mining in cancer bioinformatics and cancer epidemiology
2009 · External reference
On behalf of the escalon consortium, serum biomarkers for the prediction of hepatocellular carcinoma
10.3390/cancers13071681 · 2021 · External reference
Synthesis of surface-functionalized molybdenum disulfide nanomaterials for efficient adsorption and deep profiling of the human plasma proteome by data-independent acquisition
10.1021/acs.analchem.2c02736 · 2022 · External reference
EASL clinical practice guidelines: management of hepatocellular carcinoma
10.1016/j.jhep.2018.03.019 · 2018 · External reference
Plasma proteome profiling to detect and avoid sample-related biases in biomarker studies
10.15252/emmm.201910427 · 2019 · External reference
ROBPCA: A new approach to robust principal component analysis
10.1198/004017004000000563 · 2005 · External reference
Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma
10.1038/s41467-023-44255-2 · 2023 · External reference
Surface Modification of Stöber Silica Nanoparticles with Controlled Moiety Densities Determines Their Cytotoxicity Profiles in Macrophages
10.1021/acs.langmuir.9b02578 · 2019 · External reference
Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona
10.1038/s41467-020-17033-7 · 2020 · External reference
Protein denaturation for in-depth serum proteome profiling and enhanced cancer diagnosis
10.1016/j.nantod.2024.102488 · 2024 · External reference
Re: Ragheed Saoud, Varat Woranisarakul, Gladell P. Paner, et al. Physician perception of grade group 1 prostate cancer
10.1016/j.euf.2023.06.011 · 2024 · External reference
Establishment and clinical application evaluations of a deep mining strategy of plasma proteomics based on nanomaterial protein coronas
10.1016/j.aca.2023.341569 · 2023 · External reference
A highly efficient protein corona-based proteomic analysis strategy for the discovery of pharmacodynamic biomarkers
10.1016/j.jpha.2022.07.002 · 2022 · External reference
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach
10.1074/mcp.m113.036095 · 2014 · External reference
Blood biomarkers of hepatocellular carcinoma: a critical review
10.3389/fcell.2024.1489836 · 2024 · External reference
Serum biomarkers for the prediction of hepatocellular carcinoma
10.3390/cancers13071681 · 2021 · External reference
EASL clinical practice guidelines on the management of hepatocellular carcinoma
10.1016/j.jhep.2024.08.028 · 2025 · External reference
Diagnosis, staging, and management of hepatocellular carcinoma: practice guidance by the American Association for the study of liver diseases
10.1002/hep.29913 · 2018 · External reference
JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 Update by the liver cancer study group of Japan
10.1159/000343875 · 2014 · External reference
Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC
10.1007/s12072-022-10381-0 · 2022 · External reference
Pre-analytical drivers of bias in bead-enriched plasma proteomics
10.1038/s44321-025-00309-0 · 2025 · External reference
Systematic evaluation of blood contamination in nanoparticle-based plasma proteomics
10.1038/s44321-025-00346-9 · 2026 · External reference
Abundant synthesis of the transformation-induced protein of neoplastic human fibroblasts, plastin, in normal lymphocytes
1985 · External reference
L-plastin regulates polarization and migration in chemokine-stimulated human T lymphocytes
10.4049/jimmunol.1103242 · 2012 · External reference
The actin-bundling protein L-plastin supports T-cell motility and activation
10.1111/imr.12102 · 2013 · External reference
Costimulation induced phosphorylation of L-plastin facilitates surface transport of the T cell activation molecules CD69 and CD25
10.1002/eji.200636320 · 2007 · External reference
LCP1 is a prognostic biomarker correlated with immune infiltrates in gastric cancer
10.3233/cbm-200006 · 2021 · External reference
Evidence for critical role of lymphocyte cytosolic protein 1 in oral cancer
10.1038/srep43379 · 2017 · External reference
Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy
10.1158/1535-7163.mct-13-0646 · 2014 · External reference
The actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner
10.1111/j.1582-4934.2009.00918.x · 2010 · External reference
Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis
10.1111/jgh.12614 · 2014 · External reference
Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation
10.1016/s0960-9822(99)80458-8 · 1999 · External reference
Identification of DOK genes as lung tumor suppressors
10.1038/ng.527 · 2010 · External reference
DOK3 is required for IFN-β production by enabling TRAF3/TBK1 complex formation and IRF3 activation
10.4049/jimmunol.1301601 · 2014 · External reference
Elevated expression of DOK3 indicates high suppressive immune cell infiltration and unfavorable prognosis of gliomas
10.1016/j.intimp.2020.106400 · 2020 · External reference
Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma
10.1186/s12935-020-01352-2 · 2020 · External reference
Elevated expression of DOK3 indicates high suppressive immune cell infiltration and unfavorable prognosis of gliomas
10.1016/j.intimp.2020.106400 · 2020 · External reference
Developmentally regulated expression of calponin isoforms and the effect of h2-calponin on cell proliferation
10.1152/ajpcell.00233.2002 · 2003 · External reference
A critical role for calponin 2 in vascular development
10.1074/jbc.m506991200 · 2006 · External reference
Role of H2-calponin in regulating macrophage motility and phagocytosis
10.1074/jbc.m801163200 · 2008 · External reference
Lentivirus-mediated shRNA targeting CNN2 inhibits hepatocarcinoma in Vitro and in Vivo
10.7150/ijms.21113 · 2018 · External reference
Ectopic expression of CNN2 of colon cancer promotes cell migration
10.21037/tcr.2019.12.61 · 2020 · External reference
Heat shock response-driven signature and DNAJB11 in HCC: A multifaceted role in prognosis, immune microenvironment, ferroptosis and therapeutic sensitivity
10.1016/j.jtherbio.2026.104415 · 2026 · External reference
Senescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance
10.1101/gad.349585.122 · 2022 · External reference
Overexpression of SLC2A1, ALDOC, and PFKFB4 in the glycolysis pathway drives strong drug resistance in 3D HeLa tumor cell spheroids
10.1002/biot.202400163 · 2024 · External reference
Dihydroartemisinin inhibits ATP6 activity, reduces energy metabolism of hepatocellular carcinoma cells, promotes apoptosis and inhibits metastasis via CANX
10.3892/ol.2024.14607 · 2024 · External reference
RGS expression in cancer: oncomining the cancer microarray data
10.3109/10799893.2013.773450 · 2013 · External reference
Prognostic significance and regulatory mechanisms of NBEAL2 in HCC
10.1016/j.asjsur.2024.03.014 · 2024 · External reference
Deciphering the matrisome: extracellular matrix remodeling in liver cirrhosis and hepatocellular carcinoma
2025 · External reference
FASN inhibition decreases MHC-I degradation and synergizes with PD-L1 checkpoint blockade in hepatocellular carcinoma
10.1158/0008-5472.can-23-0966 · 2024 · External reference
Complement C1q is a key player in tumor-associated macrophage-mediated CD8+ T cell and NK cell dysfunction in malignant pleural effusion
10.7150/ijbs.100607 · 2024 · External reference
Progranulin regulates inflammation and tumor
10.2174/1871523018666190724124214 · 2020 · External reference
